Evidence map›Paper›PMID 36153643›Full record

ArticleClinical cardiology2022

A remote hypertension management program clinical algorithm.

Hunter Nichols, Christopher P Cannon, Benjamin M Scirica, Naomi D L Fisher

Open access · goldAbstract read
In one paragraph

Article in Clinical cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Primary Prevention of Cardiovascular Disease in Women.Methodist DeBakey cardiovascular journal · 2024
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hunter NicholsDivision of Cardiovascular Medicine, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-2119-6140
Christopher P CannonDivision of Cardiovascular Medicine, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-4596-2791
Benjamin M SciricaDivision of Cardiovascular Medicine, Boston, Massachusetts, USA.
Naomi D L FisherBrigham and Women's Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-1649-1441
Brigham and Women's Hospital · US

Funding

Mass General Brigham
6 · The paper itself

Abstract

introductionHypertension is the leading risk factor for death, affecting over one billion people worldwide, yet control rates are poor and stagnant. We developed a remote hypertension management program that leverages digitally transmitted home blood pressure (BP) measurements, algorithmic care pathways, and patient-navigator communications to aid patients in achieving guideline-directed BP goals.

methodsPatients with uncontrolled hypertension are identified through provider referrals and electronic health record screening aided by population health managers within the Mass General Brigham (MGB) health system. Non-licensed patient navigators supervised by pharmacists, nurse practitioners, and physicians engage and educate patients. Patients receive cellular or Bluetooth-enabled BP devices with which they monitor and transmit scheduled home BP readings. Evidence-based medication changes are made according to a custom hypertension algorithm approved within a collaborative drug therapy management (CDTM) agreement with MGB and implemented by pharmacists. Using patient-specific characteristics, we developed different pathways to optimize medication regimens. The renin-angiotensin-aldosterone system-blocker pathway prescribed ARBs/ACE inhibitors first for patients with diabetes, impaired renal function, and microalbuminuria; the standard pathway started patients on calcium channel blockers. Regimens were escalated frequently, adding thiazide-type diuretics, and including beta blockers and mineralocorticoid receptor antagonists if needed. DISCUSSION: We have developed an algorithmic approach for the remote management of hypertension with demonstrated success. A focus on algorithmic decision-making streamlines tasks and responsibilities, easing the potential for scalability of this model. As the backbone of our remote management program, this clinical algorithm can improve BP control and innovate the management of hypertension in large populations.

Indexed as

Angiotensin Receptor AntagonistsHypertensionAlgorithmsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersHumansAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAntihypertensive AgentsCalcium Channel Blockersalgorithmic managementAngiotensin II receptor blockers (ARBs) and Angiotensin-converting enzyme (ACE) inhibitorsbeta blockerscalcium channel blockers (CCBs)CDTMcollaborative drug therapy managementhypertensionmineralocorticoid receptor antagonistspharmacythiazide diuretics

Identifiers

PMID36153643
PMCPMC9748761
OpenAlexW4297911651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.